211 related articles for article (PubMed ID: 20631161)
1. Copper and ceruloplasmin abnormalities in Alzheimer's disease.
Brewer GJ; Kanzer SH; Zimmerman EA; Celmins DF; Heckman SM; Dick R
Am J Alzheimers Dis Other Demen; 2010 Sep; 25(6):490-7. PubMed ID: 20631161
[TBL] [Abstract][Full Text] [Related]
2. Association Between Serum Ceruloplasmin Specific Activity and Risk of Alzheimer's Disease.
Siotto M; Simonelli I; Pasqualetti P; Mariani S; Caprara D; Bucossi S; Ventriglia M; Molinario R; Antenucci M; Rongioletti M; Rossini PM; Squitti R
J Alzheimers Dis; 2016; 50(4):1181-9. PubMed ID: 26836154
[TBL] [Abstract][Full Text] [Related]
3. Copper, ceruloplasmin and superoxide dismutase in patients with Alzheimer's disease . a case-control study.
Snaedal J; Kristinsson J; Gunnarsdóttir S; Olafsdóttir ; Baldvinsson M; Jóhannesson T
Dement Geriatr Cogn Disord; 1998; 9(5):239-42. PubMed ID: 9701674
[TBL] [Abstract][Full Text] [Related]
4. Ceruloplasmin fragmentation is implicated in 'free' copper deregulation of Alzheimer's disease.
Squitti R; Quattrocchi CC; Salustri C; Rossini PM
Prion; 2008; 2(1):23-7. PubMed ID: 19164917
[TBL] [Abstract][Full Text] [Related]
5. Excess of serum copper not related to ceruloplasmin in Alzheimer disease.
Squitti R; Pasqualetti P; Dal Forno G; Moffa F; Cassetta E; Lupoi D; Vernieri F; Rossi L; Baldassini M; Rossini PM
Neurology; 2005 Mar; 64(6):1040-6. PubMed ID: 15781823
[TBL] [Abstract][Full Text] [Related]
6. Patients with Increased Non-Ceruloplasmin Copper Appear a Distinct Sub-Group of Alzheimer's Disease: A Neuroimaging Study.
Squitti R; Simonelli I; Cassetta E; Lupoi D; Rongioletti M; Ventriglia M; Siotto M
Curr Alzheimer Res; 2017; 14(12):1318-1326. PubMed ID: 28669331
[TBL] [Abstract][Full Text] [Related]
7. Elevated serum copper and ceruloplasmin levels in Alzheimer's disease.
Park JH; Lee DW; Park KS
Asia Pac Psychiatry; 2014 Mar; 6(1):38-45. PubMed ID: 23857910
[TBL] [Abstract][Full Text] [Related]
8. Non-Ceruloplasmin Copper as a Stratification Biomarker of Alzheimer's Disease Patients: How to Measure and Use It.
Squitti R; Ventriglia M; Granzotto A; Sensi SL; Rongioletti MCA
Curr Alzheimer Res; 2021; 18(7):533-545. PubMed ID: 34674622
[TBL] [Abstract][Full Text] [Related]
9. Copper subtype of Alzheimer's disease (AD): meta-analyses, genetic studies and predictive value of non-ceruloplasmim copper in mild cognitive impairment conversion to full AD.
Squitti R
J Trace Elem Med Biol; 2014 Oct; 28(4):482-5. PubMed ID: 25066791
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis of serum non-ceruloplasmin copper in Alzheimer's disease.
Squitti R; Simonelli I; Ventriglia M; Siotto M; Pasqualetti P; Rembach A; Doecke J; Bush AI
J Alzheimers Dis; 2014; 38(4):809-22. PubMed ID: 24072069
[TBL] [Abstract][Full Text] [Related]
11. Copper, ceruloplasmin, superoxide dismutase and iron parameters in Parkinson's disease.
Tórsdóttir G; Kristinsson J; Sveinbjörnsdóttir S; Snaedal J; Jóhannesson T
Pharmacol Toxicol; 1999 Nov; 85(5):239-43. PubMed ID: 10608487
[TBL] [Abstract][Full Text] [Related]
12. ATP7B variants as modulators of copper dyshomeostasis in Alzheimer's disease.
Squitti R; Polimanti R; Siotto M; Bucossi S; Ventriglia M; Mariani S; Vernieri F; Scrascia F; Trotta L; Rossini PM
Neuromolecular Med; 2013 Sep; 15(3):515-22. PubMed ID: 23760784
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal analysis of serum copper and ceruloplasmin in Alzheimer's disease.
Rembach A; Doecke JD; Roberts BR; Watt AD; Faux NG; Volitakis I; Pertile KK; Rumble RL; Trounson BO; Fowler CJ; Wilson W; Ellis KA; Martins RN; Rowe CC; Villemagne VL; Ames D; Masters CL; AIBL research group ; Bush AI
J Alzheimers Dis; 2013; 34(1):171-82. PubMed ID: 23168449
[TBL] [Abstract][Full Text] [Related]
14. Clinical utility of copper, ceruloplasmin, and metallothionein plasma determinations in human neurodegenerative patients and their first-degree relatives.
Arnal N; Cristalli DO; de Alaniz MJ; Marra CA
Brain Res; 2010 Mar; 1319():118-30. PubMed ID: 20026314
[TBL] [Abstract][Full Text] [Related]
15. Ceruloplasmin levels in the human superior temporal gyrus in aging and Alzheimer's disease.
Connor JR; Tucker P; Johnson M; Snyder B
Neurosci Lett; 1993 Sep; 159(1-2):88-90. PubMed ID: 8264985
[TBL] [Abstract][Full Text] [Related]
16. Non-Ceruloplasmin Copper Distincts Subtypes in Alzheimer's Disease: a Genetic Study of ATP7B Frequency.
Squitti R; Ventriglia M; Gennarelli M; Colabufo NA; El Idrissi IG; Bucossi S; Mariani S; Rongioletti M; Zanetti O; Congiu C; Rossini PM; Bonvicini C
Mol Neurobiol; 2017 Jan; 54(1):671-681. PubMed ID: 26758278
[TBL] [Abstract][Full Text] [Related]
17. Serum Copper is not Altered in Frontotemporal Lobar Degeneration.
Squitti R; Fostinelli S; Siotto M; Ferrari C; Binetti G; Benussi L; Rongioletti M; Ghidoni R
J Alzheimers Dis; 2018; 63(4):1427-1432. PubMed ID: 29843237
[TBL] [Abstract][Full Text] [Related]
18. Copper Imbalance in Alzheimer's Disease: Meta-Analysis of Serum, Plasma, and Brain Specimens, and Replication Study Evaluating
Squitti R; Ventriglia M; Simonelli I; Bonvicini C; Costa A; Perini G; Binetti G; Benussi L; Ghidoni R; Koch G; Borroni B; Albanese A; Sensi SL; Rongioletti M
Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34209820
[TBL] [Abstract][Full Text] [Related]
19. Cholesterol, copper and Abeta in controls, MCI, AD and the AD cholesterol-lowering treatment trial (ADCLT).
Sparks DL; Petanceska S; Sabbagh M; Connor D; Soares H; Adler C; Lopez J; Ziolkowski C; Lochhead J; Browne P
Curr Alzheimer Res; 2005 Dec; 2(5):527-39. PubMed ID: 16375656
[TBL] [Abstract][Full Text] [Related]
20. Copper, ceruloplasmin and superoxide dismutase (SOD1) in patients with Down's syndrome.
Tórsdóttir G; Kristinsson J; Hreidarsson S; Snaedal J; Jóhannesson T
Pharmacol Toxicol; 2001 Dec; 89(6):320-5. PubMed ID: 11903959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
